FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · The FTC alleges that the three PBMs created a perverse drug rebate system that prioritizes high rebates from drug manufacturers, leading to artificially inflated insulin list prices.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
WEB1 day ago · Sept. 20, 2024. The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin...
FTC sues pharmacy benefit managers for inflating price of insulin …
WEB3 hours ago · In a new lawsuit filed Friday, the Federal Trade Commission said it's going after one link in the chain: pharmacy benefit managers (PBMs). The FTC brought action against the top PBMs — CVS ...
FTC sues insulin middlemen, saying they pocket billions while …
WEB3 hours ago · The FTC brought action against the top PBMs — CVS Health's Caremark Rx, Cigna's Express Scripts, and United Health Group's OptumRx — saying the companies created a "perverse drug rebate system" that artificially inflates the cost of insulin.
FTC sues drug middlemen for allegedly inflating insulin prices
WEB1 day ago · The FTC has been investigating PBMs since 2022. The agency’s suit argues that the three PBMs have created a “perverse” drug rebate system that prioritizes high rebates from drugmakers, which...
FTC Further Expands Inquiry Into Prescription Drug Middlemen …
WEBJun 8, 2023 · As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued a compulsory order to a third group purchasing organization (GPO) that negotiates drug rebates on behalf of PBMs.
High insulin prices spur a federal lawsuit ... - Associated Press News
WEB1 day ago · Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the Federal Trade Commission alleged in a lawsuit filed Friday.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
FTC sues CVS, Cigna, UnitedHealth PBMs over insulin prices - STAT
WEB1 day ago · The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that...
Skip to content